Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy. [electronic resource]
Producer: 20081204Description: 1032-8 p. digitalISSN:- 1556-1380
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Deoxycytidine -- administration & dosage
- Docetaxel
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Prognosis
- Salvage Therapy
- Survival Rate
- Taxoids -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.